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Abstract
Background: Skin tears are common in older adults and those taking steroids and warfarin. They are traumatic, often
blunt injuries caused by oblique knocks to the extremities. The epidermis may separate from the dermis or both layers
from underlying tissues leaving a skin flap or total loss of tissue, which is painful and prone to infection. ‘Dermatuff™’
knee-length socks containing Kevlar fibres (used in stab-proof vests and motorcyclists’ clothing) aim to prevent skin
tears. The acceptability of the socks and the feasibility of a randomised controlled trial (RCT) had not been explored.
Methods: In this pilot parallel group RCT, 90 people at risk of skin-tear injury from Devon care homes and primary care
were randomised to receive the socks or treatment as usual (TAU). The pilot aimed to estimate parameters to inform
the design of a substantive trial and record professionals’ views and participants’ acceptability of the intervention and
of study participation.
Results: Participants were randomised from July 2013 and followed up until February 2015. Community participants
were easier to recruit than care homes residents but were 10 years younger on average and more active. To recruit 90
participants, 395 had to be approached overall as 77% were excluded or declined. Seventy-nine participants (88%)
completed the trial and 27/44 (61%) wore the socks for 16 weeks. There were 31 skin tear injuries affecting 18 (20%) of
the 90 participants. The TAU group received more injuries, more repeated episodes, and larger tears with greater
severity. Common daily diary reasons for not wearing the socks included perceived warmth in hot weather or not
being available (holiday, in hospital, bed rest). Resource use data were obtainable and indicated that sock wearing gave
a reduction in treatment costs whilst well-completed questionnaires showed improvements in secondary outcomes.
Conclusions: This pilot trial has successfully informed the design and conduct of a future definitive cost-effectiveness RCT.
It would need to be conducted in primary care with 880 active at-risk, elderly patients (440 per arm). Skin tear incidence
and quality of life (from EQ5D5L) over a 4-month period would be the primary and secondary outcomes respectively.
Trial registration: ISRCTN, ISRCTN96565376.
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Background
Skin tears are traumatic wounds involving a piece of skin of
varying size being peeled away from underlying tissues ei-
ther completely or leaving a partial or intact skin flap. They
often occur as a result of rubbing, an abrasion or a glancing
blow to an arm or leg (e.g. from a fall or being struck or
poked obliquely). Until 2011, the most commonly cited def-
inition of a skin tear was that of Payne and Martin: ‘A skin
tear is a traumatic injury occurring principally on the ex-
tremities of older adults as a result of shearing or friction
forces which separate the epidermis from the dermis (par-
tial thickness wound) or which separate both the epidermis
and the dermis from underlying structures (full-thickness
wound)’ [1]. This was superseded in 2011 [2] by the iSTap
(International Skin Tears Advisory Panel) definition ‘A skin
tear is a wound caused by shear, friction, and/or blunt force
resulting in separation of skin layers. A skin tear can be
partial-thickness (separation of the epidermis from the der-
mis) or full-thickness (separation of both the epidermis and
dermis from underlying structures).’ These are common in-
juries [2–10]; recent data from Japan found that point-
prevalence was 3.9% among 410 patients in long-term care
[11] and two elderly care rehabilitation units in Australia
reported 10% [12]. A non-systematic review [9] reported
skin-tear incidence between 2.23 and 41.5% and prevalence
between 6.6 and 23.5% in US care homes. In Pennsylvania,
skin tear reporting became mandatory for healthcare facil-
ities in 2004 [13], where 88.2% of the 2807 skin tears were
in patients aged over 65 years. Fourteen percent of an
American 120-bed nursing home population sustained a
skin tear per month with an average of 2.67 tears per resi-
dent [14]. A recent wound point prevalence audit under-
taken in North Devon [15] in 16 care homes revealed 195
wounds among 115 of 458 residents (25%). Traumatic in-
juries (skin tears) were the second most common wound
type (37, 19%) after pressure ulcers (87, 45%).
Rayner et al. [16] conducted a review of the literature to
identify studies that described patient and skin character-
istics associated with skin tears. The most common pa-
tient characteristics from eight published articles and one
unpublished study were a history of skin tears, impaired
mobility and impaired cognition. Skin characteristics asso-
ciated with skin tears included senile purpura, ecchymosis
and oedema. Several changes occur in the skin that in-
crease its susceptibility to traumatic injury [17, 18]. These
changes are due to intrinsic ageing and cumulative extrin-
sic factors such as photoageing and polypharmacy. They
include vascular atrophy and deterioration of the dermis
as collagen and elastin fibres become more sparse and dis-
ordered, holding the skin layers together less tightly [19].
Older patients may have also taken oral steroids that com-
promise skin integrity and tensile strength and cause
wounds to heal more slowly [20–23]. They may also be
less aware that an injury has occurred due to decreased
pain perception and tactile sensitivity, including diabetic
neuropathy [24]. Fragile skin is most common in people
aged over 70. There were 7.4 million people in this age
group in the UK in 2011, estimated to increase to 11.2
million in 2030 [25]. Skin tears are unpleasant and pro-
voke anxiety. They can take a long time to heal and are
prone to infections. Whilst arm injuries are more com-
mon, leg injuries may develop into leg ulcers, which may
require lengthy, expensive treatment [26]. Typical causes
of skin tears include wheelchairs, other mobility aids,
bumping into obstacles, transfers and falls. There are best
practice guidelines for treatment and preventing infections
and ulcers [27]. Prevention includes staff education, regu-
lar assessment, ensuring clothing does not rub, removing
obstacles and moisturising the skin [9, 28, 29].
With advancing age, the process of normal wound
healing is subject to disruptions and aberrations which
can delay the process and predispose the individual to
the effects of various factors involved in the formation
of a chronic wound [30]. The impact of these changes
can be seen in all phases of wound repair, and disruption
of any step can lead to an overall delay in healing of be-
tween 20 and 60% [31, 32]. Poor management of skin
tears can lead to the development of a chronic wound,
such as a leg ulcer, with the subsequent impact to the
patients’ physical and mental wellbeing [33]. Advancing
age, reduced circulation and epidermal turnover rate
and also polypharmacy, co-morbidities and nutritional
deficits [34, 35] have all been identified as increasing the
risk of a chronic wound developing from the initial skin
tear.
Skin tears are often treated in the community [36];
however, for more severe tears and if a patient develops
complications such as an infection, or is in need of sur-
gical debridement, they will need to be referred to sec-
ondary care. In a recent study looking at admissions
with skin tears between January 2010 and July 2013 at
Charing Cross and Westminster Hospital [36], 73 pa-
tients presented with pretibial lacerations, 81% of which
were as an acute referral. The remaining patients had
previously been treated in the community but the
wound either had failed to heal or had developed an in-
fection. Eighty-two percent of the patients presenting re-
quired surgical debridement and grafting. Mean length
of hospital stay was 11 days for those needing a surgical
intervention and 5 days for those undergoing conserva-
tive management. These findings are similar to those
seen by Rees et al. [37] where the mean hospital stay
was found to be 9 days. Three of the patients died before
discharge and a further 3 died in the follow up period,
with two of the deaths thought to be directly attributable
to the skin tears. Another consequence of developing a
skin tear is that previously independent living individuals
may end up in residential care, up to 20% [37].
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One possible way to prevent skin tears may be to wear
suitable protective clothing. We describe here a pilot trial
of protective socks conceived and developed by a member
of the public after receiving many such tears. The protect-
ive socks were manufactured by Dermatuff Limited, Wood-
bury, Devon UK. The socks are CE marked and registered
with the Medicines and Healthcare products Regulatory
Authority (MHRA) as ‘Skin Tears Protection System Wear’,
a class I medical device. Materials used in the manufacture
of the socks are in conformity with all relevant and required
standards including the ISO 10993 series evaluating bio-
compatibility of a medical device prior to a clinical study.
The socks have a leg section woven from Kevlar [38] and
elasticated nylon using the ‘terry sandwich’ method. This
gives a flat, slightly ribbed and stretchy, outer woven base
which provides a tough, cut and abrasion-resistant exterior.
There is a mesh of loops on the inside to provide a cush-
ioning and impact resistant inner layer. The stretchiness is
sufficient to fit a range of leg diameters within each size
without applying excess pressure, and the socks are held up
with a light elastane soft top band. The foot of the socks is
manufactured from cotton as laceration protection is not
usually required for the feet. Compression hosiery could be
worn underneath if required as the socks do not offer any
compression themselves. Patients requiring such hosiery
were excluded from this study however, as this may con-
found any protective effects.
Apart from small-scale, uncontrolled testing during
development, there has been no trial of the effectiveness
and cost-effectiveness of this unique and innovative ap-
proach to skin tear prevention.
This pilot study addressed key areas of uncertainty
around the running of a full trial by testing the feasibility
and acceptability of the research design, methods and
proposed outcome measures.
Specific objectives of this pilot study were as follows:
 To determine recruitment, retention and attrition rates
 To consider appropriate outcome measures (including
an evaluation of two systems for skin-tear classifica-
tion), to assess the processes for capturing outcome
data and to refine the clinical protocol for a full trial
 To refine the intervention if appropriate through
qualitative work on acceptability
 To estimate concordance with the intervention
 To estimate rates of questionnaire completion
 To obtain baseline estimates of scores on the proposed
outcome measures in this clinical population and
estimate the variability of outcomes to inform the
sample size of the definitive trial
 To help establish the eligibility criteria for the future
definitive trial
 To estimate the ability to obtain cost and effectiveness
measures
 To obtain feedback from care homes regarding the
acceptability of the study
Methods
Detailed methodology including study design, random-
isation, eligibility criteria and study protocol are de-
scribed in a separate protocol paper [39]. The study
received approval by the Cornwall and Plymouth NRES
Research Ethics Committee.
Study design
The study was an open, parallel group, pilot randomised
controlled study in which participants were randomised in
equal proportions to either the ‘intervention group’
(Socks) or the ‘control group’ receiving treatment as usual
(TAU). Participants in the intervention group were asked
to wear the protective socks during each day (‘waking
hours’) for a period of 16 weeks whilst participants in the
control group wore their usual clothing. The study was
conducted in Devon, UK, and aimed to recruit 90 partici-
pants, 45 in each arm. Recruitment was intended to be en-
tirely from care homes, but because of slow recruitment
due to low interest in participation and mental capacity
problems, an ethics amendment granted in October 2013
allowed further recruitment from the community.
Key outcome measures were collected at baseline, at
the end of the 16-week period and within 7 days follow-
ing any skin tear. Experiences of using the socks and/or
taking part in the study were captured through semi-
structured interviews with a purposive sample of partici-
pants from both the intervention and control arms of
the study. Focus groups with care home staff and other
professionals captured their perspectives of the study.
Blinding was not possible for participants or research
nurses due to the nature of the intervention but was
possible for the data analyst by coding the group alloca-
tion in the data file.
Study setting
Inclusion criteria
Participants were adults aged 65 years and over at risk
of skin tears. Inclusion and exclusion criteria are de-
scribed in the protocol paper [39].
Recruitment
Participants were recruited primarily from Care Quality
Commission-registered care homes with the advice of the
local Tissue Viability Service. Residents of care homes are
widely recognised to be an under-researched population
and at high risk of suffering skin tears. For logistical rea-
sons, in order to maximise efficiency in term of research
nurse resource, recruitment efforts were focused on three
geographical areas successively (Exeter, Exmouth/Sidmouth
Powell et al. Pilot and Feasibility Studies  (2017) 3:43 Page 3 of 22
and Mid Devon, roughly representing urban, coastal and
rural areas, respectively).
In order to augment recruitment, patients in the com-
munity were also invited to participate. Community-
dwelling participants were recruited through GP practices
supported by the Clinical Research Network (South West
Peninsula) or via the ‘Exeter 10000’ research volunteer
bank managed by the NIHR Exeter Clinical Research Fa-
cility (Exeter CRF). GP staff searched for patients aged
65 years or older who had used oral steroids for more than
a month in the prior 12-month period. Lists generated
from the search were screened for suitability by a doctor
at each participating practice and unsuitable patients ex-
cluded, e.g. terminal illness and mental illness. Home visits
for consent and for subsequent follow-up visits were
sometimes replaced by clinic visits (at a local community
hospital or GP surgery for example) if available and mutu-
ally convenient.
Baseline assessment
Research nurses provided potential participants with the
approved study information, confirmed eligibility and ob-
tained written informed consent. Subsequently, baseline
questionnaires were completed by all participants. These
included a standardised measure of health status (EQ-5D-
5L) [40], an assessment of capability (ICECAP-O) [41]
and an assessment of fear of falling (Short FES-I) [42].
Randomisation/allocation
Randomisation was achieved by means of a bespoke on-
line system managed by the Peninsula Clinical Trials
Unit; participants were allocated to the intervention
group or the control group in equal proportions, using
blocks of fixed size to generate the allocation sequence
and achieve balance in the numbers of participants allo-
cated to each group. Research nurses working in the
community were able to access the randomisation ser-
vice using smart phones.
Interventions
Three pairs of intervention socks were provided to each
participant in the intervention group. The research nurse
carried a stock of the socks and provided the correct size in
a choice of either charcoal grey or beige colour. Participants
allocated to the intervention group were asked to wear the
socks during their waking hours every day for a period of
16 weeks, starting from the morning following the day they
signed consent, which was designated as ‘day 1’. Care home
staff, where applicable, were asked to encourage partici-
pants to wear the socks and to assist them to put them on,
if necessary. However, it was emphasised that if participants
became unwilling to wear the socks or wanted to take them
off, they were free to make that choice. Participants contin-
ued to wear their normal footwear during participation in
the study. Participants allocated to receive routine care
were managed as usual. This included any routine proce-
dures to reduce the risk of lacerations, but otherwise they
wore their normal clothing.
Post-randomisation assessments
Participants allocated to wear the socks were given the first
of 16 weekly diaries at this visit and were asked by the re-
search nurse to complete the diary on a daily basis. Partici-
pants were asked to use the diary to record the extent to
which they wore the socks each day and the reasons for not
wearing them or removing them (if applicable), plus any
negative or positive comments about wearing them. A new
weekly diary was provided to the participant each week.
Feasibility outcome measures
Outcome measures for the pilot study were as follows:
 Recruitment rate for homes
 Proportion of participants (home residents) eligible
 Recruitment rate for participants
 Attrition and loss to follow-up
 Ascertainment of injuries
 Completion and completeness of study
questionnaires and diaries
 Estimates of the distribution of outcome measures
 Feasibility of the workload
 Acceptability of the intervention to participants
 Acceptability of study participation to participants
Outcome measures
The primary outcome measure for a future substantive
study was incidence of skin tears (a traumatic injury to
the skin of the lower legs resulting in separation of skin
layers). Skin tears were reported to the research nurses
by care home staff or self-reported by participants in the
community. Incidence was also expressed by the number
of ‘skin tear-free days’. Each participant entered the
study with no unhealed skin tear injuries and remained
in the study (unless withdrawn prematurely) for 112 days
(i.e. 16 full weeks). Therefore, each participant had the
potential to experience 112 skin tear-free days. In the
event of a skin tear injury, the number of days from the
date of injury until the date it was healed was subtracted
from 112 to give the number of skin tear-free days. A
healed injury was defined as one which had an absence
of scab and full epithelial covering that did not require
continuance of dressing for absorption of exudate
(sometimes a dressing may be left on a healed but deli-
cate wound for a few days after healing).
Skin tear injuries occurring during the trial were mea-
sured using the ‘Visitrak’ (Smith & Nephew, Australia) grid
tracing system (length, breadth and area) and classified by
trained research nurses using both the Payne and Martin
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[1] and the Skin Tear Audit Research (STAR) [43] classifi-
cation systems. Date of healing, description of cause, de-
scription of initial management (dressing type, healthcare
professional intervention), lower-leg clothing in place at
time of injury and, for intervention group participants, the
presence or absence of protective socks at the time of injury
were all recorded by research nurses for each skin tear in-
jury occurrence. The protocol stipulated that skin tear as-
sessments would be performed within 24 h upon learning
of an injury, if possible.
Each injury was photographed by the research nurses
according to a trial-specific protocol. Photos were trans-
ferred to a blind tissue viability specialist nurse for clas-
sification according to the described severity scores. This
grading served to inform an assessment of the reliability
of the reported grading.
Secondary outcome measures
The secondary outcome measures were as follows:
 Collected at baseline, 16 weeks and in the event of a
skin tear injury:
Standardised measure of health status (EQ-5D-5 L)
Assessment of capability (ICECAP-O)
Assessment of fear of falling (Short FES-I)
 Disease-specific quality of life measured by Cardiff
Wound Impact Schedule. Collected in the event of a
skin tear injury, within a week after the injury and at
16 weeks (from participants who have had a skin tear)
 Adverse reactions to the socks and serious adverse
events
 Skin-tear injury-related healthcare resource use
(collected in the event of a skin tear injury)
Skin tear severity rating scales: inter- and intra-agreement
One of the objectives for the pilot study was to evaluate the
two skin tear classification systems available, in terms of
their suitability for use in a future substantive trial. All skin
tears were therefore assessed and categorised by the re-
search nurses according to both the ‘Payne Martin Classifi-
cation System for Skin Tears’ [1] and the ‘STAR Skin Tear
Classification System’ [43]. Digital photographs were taken
of each wound and stored on a secure computer drive
within the RD&E Trust. AK made an independent, blind
assessment of the categorisation of the wound severity.
Intra-rater and inter-rater comparisons were then made.
Sample size and statistical analyses
Regarding the sample size required for the pilot, in order
to estimate a 50% recruitment rate with a 95% confi-
dence interval of +/− 10% points (i.e. an estimate of be-
tween 40 and 60% recruitment) within a pool of at least
1000 eligible care home residents for the trial living in
care homes in Exeter, Mid and East Devon, a total of 88
patients would be required (44 in each arm). Regarding
concordance, if only 50% of recruited patients continue
to use the socks for the duration of the trial, 90 patients
would enable us to estimate that with +/− 10% precision
(from 40 to 60% concordance). StatsDirect 2.6.6 (Al-
trincham, UK), which used the methods of Colton [44]
and Feinstein [45].
We report and present data according to the relevant
CONSORT statement [46]. The primary analyses were all
pre-specified in a detailed statistical analysis plan approved
by Trial Steering Group before the analyses started. As this
was a pilot study, a purely descriptive analysis was under-
taken. The study data were analysed using the statistical
package SPSS v. 23 (IBM Corp, New York). Missing data
were investigated and the proportions missing were re-
corded. Multiple imputation methods or specific imput-
ation methods recommended by the authors of the
questionnaires were used to obtain realistic estimates of
scores for future planning of questionnaire usefulness. All
the questionnaires concerning acceptability of the socks
were scored and summarised using appropriate measures
of central tendency and dispersion. Data on lacerations
were also summarised in a similar way. Agreement on
wound grading between research nurses and a blinded tis-
sue viability expert (AK) was assessed from anonymised
photographs using Cohen’s weighted kappa. Numbers of
eligible residents, recruitment, attrition and loss to follow-
up (as per the Consolidated Standards of Reporting Trials
(CONSORT) diagram) were reported as proportions and
confidence intervals wherever appropriate. The main ana-
lysis described skin tear-free days and the incidence and se-
verity of skin lacerations in each group.
The pilot study was intended to determine the feasibil-
ity of how the outcomes can be measured. These were
used to inform the sample size of the future substantive
randomised controlled trial. In that trial, we intend to
compare the incidence of skin damage between the two
groups on an intention-to-treat basis and the size of any
wounds by objective assessors (research nurses).
Patient involvement
The trial intervention socks were conceived and devel-
oped by a member of the public who has suffered from
skin tears himself. During the design of this study, a sep-
arate patient representative contributed to the develop-
ment of the grant application and, later, to the study
protocol and participant facing documentation after
funding had been awarded. There were also other pa-
tient representatives on both the Trial Management
group and on the Trial Steering Committee, who helped
to oversee progress of the trial and provided a patient’s
perspective on aspects of trial conduct. A lay summary
of the study findings will be made available to partici-
pants at www.medicalresearchplymouth.org.uk.
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Adverse and serious adverse events
Any adverse events which were serious and/or related to
study procedures or the socks were recorded. Multiple
symptoms were recorded as separate events. The events
were reported to the Chief Investigator, Sponsor and the
Peninsula Clinical Trials Unit on a designated report
form which captured the research nurse’s opinion on the
relatedness of the event to study procedures/interven-
tion and also on the expectedness of the event. Adverse
reactions to the socks were expected to be uncommon.
The following list of potential symptoms was used as a
reference when assessing the expectedness of adverse
device effects.
 Allergic-type skin reaction
 Miliaria (heat rash)
 Chafing
 Excessive sweating under the socks
 Skin tears or bruising caused by putting on or
removing the socks
 Pain, discomfort, numbness, swelling or any other
condition caused by socks which were too tight
 Falls or other accidents caused by slipping or
tripping as a result of wearing the socks
Cumulative summaries of adverse reactions were
reviewed periodically by the Trial Steering Committee.
Economic evaluation
The economic evaluation in the future substantive trial
will estimate the additional NHS cost per QALY (qual-
ity-adjusted life years) gained by the use of these protect-
ive socks. In this pilot, QALY estimations were based on
the EuroQol descriptive system (EQ-5D-5L) collected at
baseline and at 16 weeks for all participants and at 7 days
after a participant incurred a skin tear injury to the leg.
The study assessed the ability to obtain cost and ef-
fectiveness measures. It aimed to collect data on the re-
sources used by the care homes, visits to/from GPs or
healthcare professionals and the NHS in the manage-
ment of skin tears. The primary source of these data
were the participants’ medical records of their normal
procedures, visits from district or tissue viability nurses,
visits to and from GPs and any care needs arising from
adverse events. The pilot study assessed whether care
home records and or participants’ medical notes were
adequate to describe resource use in a costable format.
Qualitative interviews and focus groups
Semi-structured qualitative interviews with 20 participants
from both study arms were conducted at the end of the
follow-up period by an independent researcher. These in-
cluded a range of participants with varying degrees of mo-
bility across the geographical areas. Experiences of using
the protective socks, their acceptability and/or taking part
in the study were captured. Participants were selected
using purposive sampling informed by research nurse data
on their clinical progress with regard to skin tears, per-
ceived protection from knocks and falls, withdrawals, ad-
verse events and any problems with the skin-tear and/or
questionnaire data collection process. In order to get a
representative sample, a range of people across different
ages and gender were interviewed as per the inclusion cri-
teria. Interviews were digitally recorded and transcribed
with the main themes identified using content analysis.
Two focus groups were convened to explore the use-
fulness of the protective socks. These groups included
professionals from the Tissue Viability Service and care
home staff with experience of participants assigned to
the intervention arm of the study. Holding two focus
groups provided easy access for staff of care homes
across the large geographical area of the pilot trial.
Results
The first participant was randomised on 30th July 2013
and the last on 2nd October 2014. Follow-up was com-
pleted in early February 2015. A total of 90 participants
were recruited, with 44 randomised to the intervention
arm and 46 to the TAU group.
Baseline characteristics
Table 1 provides baseline characteristics of participants
and demonstrates reasonable balance between the two
randomised arms, although a slightly higher proportion
of women were allocated to the intervention group.
Recruitment and eligibility
See CONSORT diagram (Fig. 1) and recruitment graph
(Fig. 2). Ninety-six care homes were identified from the
CQC database and were approached. They contained
2142 residents, of which 315 suitable residents (15%)
were identified by care home managers and approached
by the research nurses. In the community, 338 patients
were identified from GP databases and screened. Of
these, 190 (56%) were sent letters about the study on
Surgery headed paper and 48 of these (25%) were
approached. A further 70 volunteers were identified
from the Exeter 10 K volunteer database. Of these, 63
(90%) were sent letters about the study and 32 of these
(51%) were approached.
Of the 395 people approached, 144 (36%) were ex-
cluded or declined to take part and 251 participants
(64%; 95% CI 59 to 68%)) received a Participant Infor-
mation Sheet (PIS). Ninety of these (36%; 95% CI 30 to
42%) gave informed consent (54 in care homes (60%), 24
from GP practices (27%) and 12 volunteers from Exeter
10 K database (13%)). Of the 54 in care homes, 16 were
from the Exeter area and 38 from Sidmouth/Exmouth.
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Table 1 Baseline characteristics
Protective socks (n = 44) Treatment as usual (n = 46) All (n = 90)
Demographics
Female sex 24 (54.55%) 18 (39.13%) 42 (46.7%)
Age, years, median (IQR) 86 (12) 85 (11) 85.5 (11)
Care home residents 27 27 54 (60%)
Female sex 14 (51.85%) 12 (44.44%) 26 (48.15%)
Age, years, median (IQR) 90 (8) 88 (9) 90 (9)
Community participants 17 19 36 (40%)
Female sex 10 (58.82%) 6 (31.58%) 16 (44.44%)
Age, years, median (IQR) 79 (16) 80 (11) 80 (12)
Fig. 1 CONSORT Diagram
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Only 54 (60%) of the participants could be recruited
from care homes because of residents’ reluctance to take
part in research or mental capacity issues. The remaining
36 (40%) were recruited from the community after ethics
amendments (see Fig. 2). Furthermore, 96 CRC approved
care homes and 315 residents had to be approached to
give a recruitment rate in care homes of 17%, 95% CI 13
to 22%. Among the three sources of participants, the high-
est conversion from ‘approached’ to ‘recruited’ was
achieved in GP practices (50%; 95% CI 35 to 65%). The
lowest conversion was in care homes (17%; 95% CI 13 to
22%). In volunteers, it was 37.5%, 95% CI 21.1 to 56.3%
(P < 0.0001). In summary, in order to recruit 90 partici-
pants, 395 had to be identified and approached by the re-
search nurses (approx. 1 in 4).
Socks
Sixteen women (67%) requested (and were fitted with)
beige socks and 8 (33%) women with grey socks.
None of the women required the large size. Thirteen
(63%) of the men requested (and were fitted with)
beige socks and 7 (37%) with grey. Most of the men
(63%) required the large size, and none of them had
the small size. The most common size used in this
trial was standard-medium (37% of participants) and
colour beige (65%).
Concordance, retention and attrition
Of the 44 participants in the socks group:
 27 participants (61.4%) wore the socks for the full
112 days.
 17 participants (38.6%) discontinued wearing the
socks.
 6 participants (13.6%) withdrew from the trial
altogether.
In the control group:
 41 participants (89.1%) completed the trial
(112 days).
 5 participants (10.9%) withdrew.
The results are shown in Table 2. Of the 17 partici-
pants who stopped wearing the socks, this occurred a
median of 14 days from allocation (IQR 27 days). Two
individuals stopped wearing them on the first day (day
0) because they did not fit properly: the foot part was
too large or socks were too long.
Primary clinical outcome: skin tear injuries
A list of all the skin tears is given in Table 3, with summary
data reported in Table 4. During the course of the trial,
there were 31 skin tear injuries affecting 18 of the 90 partic-
ipants in the trial (20%) over a period of 112 days—8 people
out of 44 (18.2%; 95% CI 8.2 to 32.7%) in the socks group
and 10/46 (21.7%; 95% CI 10.9 to 36.3%) in the control
group. Seven of the 18 first-time tears (38.9%) occurred
within the first month. Six participants had repeated skin
tears, and the maximum number of repeated tears was 8.
Fig. 2 Target vs actual recruitment
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The outcome measure ‘skin tear-free days’ was highly
skewed because 80% of participants in the trial experienced
no injuries (112 skin tear-free days). The median (IQR) time
to the first injury was 38 (29) days in the socks group and
28 (63) days in the TAU group. The hazard ratio (95% CI)
of group 1 (socks) vs. group 2 (TAU) = 0.81 (0.32 to 2.04).
The usual care group received more tear injuries, more
repeated episodes, larger tears (socks group, median
1.5 cm2 (IQR 2.92 cm2); TAU median 2 cm2 (IQR
2.18 cm2)) and more severe tears which would require
emergency treatment (STAR grade 3: socks group 1/10
(10%); TAU group 5/21 (24%)). If STAR grade 2b and 3 are
combined, this amounts to socks group 5/10 (50%); TAU
12/21 (57%).
Among the 54 care home residents, nine (17%) re-
ceived tears: four in the socks group (one tear each) and
five in the TAU group (total eight tears). In the commu-
nity, nine of the 36 participants (25%) suffered a tear:
four in the socks group (total six tears) and five in the
TAU group (total 13 tears).
Only 2 of the 8 people with skin tears in the socks
group (cases #41 and #85, marked with * in Table 3)
were definitely wearing the intervention socks at the
time of the injury. Also, one of these (#41) was noted by
care home staff to habitually roll their socks down. Their
injury occurred during the hot summer of 2014 when
UK temperatures reached 27 °C [47].
Causes of the skin tears differed between the care
home and community participants. In care homes, the
12 tears were caused by falls (4) including falling out of
bed and in transferring from bed to chair; knocks against
objects (4) such as walking aids, bathroom furniture and
blunt or sharp edges and ‘unknown’ (4) where the par-
ticipants could not recall the cause. In the community,
the 19 tears were caused by gardening activities (7) in-
cluding two falls in the garden; knocks against objects
(4) such as a door, a door frame, wine rack and recycling
bin; overnight in bed (3) on the bed frame and simply by
dragging bed sheets over their legs; dropping objects be-
ing carried (2)—a full cardboard box and a heavy crate
that scraped the legs; and ‘other’ (3) such as putting or-
dinary socks on in the morning (from fingernails), a
penetrating injury of unknown origin and a fall indoors.
Skin tear severity rating scales: inter- and intra-rater
agreement
Table 5 gives reliability data for the two severity rating
scales. There was good agreement between the Payne
Martin and STAR classification systems, whether
assessed by a nurse (kappa = 0.7) or a tissue viability ex-
pert (kappa 0.65). However, the inter-rater reliability,
comparing nurse with expert, was only ‘fair’, for both
Payne Martin (kappa 0.26) and STAR (kappa 0.22).
Adverse events
Non-serious adverse events were reported only if a pos-
sible causal relationship to intervention or trial partici-
pation was suspected. No events were attributed to trial
participation. Twelve events were reported as having a
causal relationship to the protective socks: 8 were classi-
fied as being mild and 4 were classified as moderate in
severity (Table 6).
As a safety measure, all serious adverse events were re-
ported regardless of relatedness to trial participation or
intervention. Ten serious adverse events (SAE’s) were re-
ported, none of which were regarded as being a reaction
to the socks or caused by taking part in the trial.
Completeness of diary data
Of the 704 weekly diaries given out, 482 (68.5%) were
returned. All diary comments were documented,
reviewed and categorised to determine how the informa-
tion would be reported. Most of the unobtainable diaries
were due to participant withdrawals. The number of
diary days that had comments written on them varied
between 0 (4 participants) and 99 (1 participant). Six
hundred eighty comments were recorded in total.
The diaries encompassed a total of 4928 participant
days for those allocated to the socks (2688 for women
and 2240 for men) to write comments. Women wrote
on 417 participant days (15.51%) and men on 263 par-
ticipant days (11.74%). Only 6 participants wrote com-
ments on 30 or more days of the 112-day follow-up
period. Themes from these comments were coded and
these are summarised in Table 7. The commonest
Table 2 Compliance with wearing the Dermatuff™ socks
Reason Stopped
wearing socks
Withdrawn
Socks uncomfortable 7
•1 legs swell up
•2 socks too long
•2 socks too warm (1 same person as for
socks too long),
•1 socks too tight
•1 developed blister
•1 socks itched
Participant too unwell (1 dying, 1 chronic
illness and too tired to put on socks)
2 2
Participant lost capacity 2 2
Previous skin problem (dry skin on heels) 1 1
Found socks unsightly/embarrassing 1
Socks did not fit (thin calves) 1
Died 1 1
No reason given 2
Total 17 6
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comment concerned the perceived warmth of the socks
(women 190 comments (45.6%); men 112 comments
(42.6%)) and in particular that the weather was too
warm to wear the socks. However, to put this into con-
text, these represent 7.1% of the total participant days
for women and 5% for men. Ninety-nine such comments
came from one participant.
A range of other comments were expressed including
wearing the socks only part of the day, wearing only one
sock (presumably after a treatment to one leg) and not
wearing them because the participant was either on holi-
day, in hospital or taking bed rest. Positive comments re-
lated to comfort and possibly offering protection from
some knocks.
Table 4 Reported skin tear injuries: incidence, skin tear-free days (STFD), size and severity using Payne-Martin (PM) and STAR grading
systems
Socks group TAU group Total
Total allocated 44 46 90
Participants with skin tears 8 (18.18%)* 10 (21.74%) 18 (20%)
Total number of skin tear injuries 10 21 31
No. with 1 injury 6 6 12
No. with 2 injuries 2 2 4
No. with 3 injuries 0 1 1
No. with 8 injuries 0 1 1
Incidence (people suffering tears) 8/44 = 0.18 10/46 = 0.22 RR = 0.84 (0.37 to 1.88)
Incidence (tears/episodes of care) 10/44 21/46 RR = 0.50 (0.26 to 0.91)
Mean (sd) total area of injury (cm2) 1.76 (1.39) 4.26 (7.61) (missing data on case 3001)
Median (IQR) total area of injury (cm2) 1.5 (2.92) 2 (2.18) (missing data on case 3001)
Median (IQR) duration (days) 26.5 (17.75) 17 (10.75) [missing data on case 3001]
Mean (sd) STFD for whole group (days) 107.2 (12.43) 105.72 (16.5)
Median (IQR) STFD for whole group (days) 112 (0) 112 (0)
PM category Ia 3 1 4
PM category Ib 1 4 5
PM category IIa 2 8 10
PM category IIb 2 2 4
PM category III 1 6 7
PM category missing 1 1
STAR category 1a 3 2 5
STAR category 1b 1 3 4
STAR category 2a 4 4
STAR category 2b 4 7 11
STAR category 3 1 5 6
STAR category missing 1 1
*Participant was definitely wearing intervention socks at the time of injury
Table 5 Reliability of Payne-Martin and STAR grading scales for skin tears
Inter-rater agreement: nurses vs. tissue viability expert (AK) Inter-scale agreement: Payne-Martin vs STAR
Payne-Martin Groups 1a, 1b, 2a, 2b and
3
STAR Groups 1a, 1b, 2a, 2b and
3
Nurse grading Tissue viability expert (AK)
grading
Observed
agreement
75% 74.1% 88.33% 90%
Expected
agreement
66.2% 66.8% 61.67% 71.39%
Kappa +/− 95% CI 0.26 (0.02 to 0.5) 0.22 (− 0.02 to 0.46) 0.70 (0.55 to 0.84) 0.65 (0.47 to 0.84)
p 0.0118 0.0264 < 0.0001 < 0.0001
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Economic evaluation
Whilst the number of different types of health profes-
sionals seen and the number of occasions were recorded,
it was not possible to obtain precise timings and dura-
tions of treatments provided by them as clinical records
were not easily obtainable in the time available. How-
ever, the costs of visits to and from healthcare profes-
sionals were calculated using Personal Social Services
Research Unit estimates of costs [48]. EQ5D5L data and
derived variables where appropriate were non-normal
(positively skewed), so estimates of the distributional
characteristics were obtained using repeated sampling
(bootstrap) methods.
The use of the protective socks resulted in reductions
in the incidence of skin tears. The trial incidence of skin
tears was 0.2029 per 100 person days in the group allo-
cated to wear the socks and 0.4076 per 100 person days
in the usual care group (odds ratio for sock wearing
0.2250 95% CI 0.0881 to 0.5748). The bootstrap median
estimate of injuries averted per 100 person days in the
sock wearing group was 2 (inter-quartile range 1 to 4).
Severity of injuries
Although the severity scores [1] do not differ between
the groups, sock wearing may be associated with a re-
duction in the length of time taken for skin tears to re-
solve (average 30.33 (s.d. 30.45) days for the injuries in
the sock wearing group and average 37.20 (s.d. 45.10) for
injuries in the usual care group).
i. Quality of life
Over the trial period, wearing socks was associated
with a higher health-related quality of life. Quality of life
was assessed using EQ-5D-5L [40] and the OHE tariff
[48]. The baseline quality of life was similar and quite
low for STOPCUTS participants (mean baseline tariff
value 0.66 (s.d. 0.23) for the sock wearers and 0.67 (s.d.
0.26) for the usual care group). The mean within trial
QALY—with ‘perfect health’ over 6 months giving a
maximum value of 0.5 QALY—was 0.211 (s.d. 0.076) for
sock wearers and 0.206 (s.d. 0.067) for the usual care
group. The bootstrap estimate of the median QALY def-
icit associated with usual care was 0.065 (inter-quartile
range 0.028 to 0.10).
ii. Costs
Wearing the protective socks resulted in the group in-
curring lower NHS costs for the treatment of skin tears.
The resources used to treat skin tears occurring during
the trial are shown in Fig. 3. The costs shown in the dia-
gram are estimates of the total NHS costs for treating all
the injuries in that branch of the decision tree until they
were resolved. The costs include the costs of the health
professionals’ time and the NHS prices for the dressings
used. Both of these costs depend on the time taken for
injuries to resolve—the duration of treatment. The time
taken for the injury to resolve varied for the injuries re-
corded in the STOPCUTS study. The shortest time for
an injury to resolve was 8 days (Payne Martin Grading
of the injury was 1a) and the longest 180 days (Payne
Martin grading of the injury was 1b). The average time
taken for injuries to resolve was 26.81 days (standard de-
viation 30.48). Overall, district nurses opted for similar
dressings to nurses from other specialisms. The main
NHS resources used were, firstly, the specialised dress-
ings used. Following guidelines [49], the dressings used
depended on the amount of skin lost in the injury, the
quantity of exudate and the general condition of the pa-
tient’s skin. The dressings used were non-adherent and
ranged from transparent film dressings to silicone-based
Table 6 Non serious adverse events listed in order of increasing severity
Summary Severity Related to socks? Resolution
Rubbing and red marking on tips of big toes Mild Possibly Recovered
Itching and discomfort of lower legs and feet Mild Probably Recovered
Unconfirmed fungal infection of heel Mild Possibly Recovered
Dry, excoriated skin Mild Possibly Recovered
Lower leg discomfort Mild Definitely Recovered
Lower leg discomfort Mild Definitely Recovered
Itchy leg, particularly at top of sock area Mild Probably Recovered
Worsening of pre-existing rash Mild Possibly N/K
Pain, discomfort and swelling Moderate Probably Recovered
Toe and foot discomfort Moderate Possibly Recovered
Itchy legs, blister on 3rd toe left foot Moderate Probably Recovered
Pain in left shoulder Moderate Possibly Recovered
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Table 7 Diary comments summarised and frequencies provided by men and women
Comment Women Men
Reasons for not wearing socks and other comments (summarised) Frequency Percent Valid percent Frequency Percent Valid percent
All pairs in the wash 14 0.52 3.36 4 0.18 1.52
Bed rest: not wearing socks 5 0.19 1.2 16 0.72 6.08
Chiropodist appointment 3 0.11 0.72 5 0.22 1.9
Diary day not completed 2 0.07 0.48 1 0.04 0.38
Difficult to put on 2 0.09 0.76
Feet and legs creamed 6 0.22 1.44 4 0.18 1.52
Foot swollen/shoe fitting issue 5 0.19 1.2 4 0.18 1.52
Forgot to wear the socks 7 0.26 1.68 2 0.09 0.76
Legs tend to swell 2 0.07 0.48
In hospital 1 0.04 0.24 9 0.4 3.42
Itching 1 0.04 0.24 6 0.27 2.28
Making legs swell/ft sweaty 1 0.04 0.24
Not wearing socks—support hose 2 0.07 0.48
Not wearing socks—trousers 1 0.04 0.24
Not wearing socks—went out 19 0.71 4.56
Not wearing socks—skirt 5 0.19 1.2
Not wearing socks—other 10 0.37 2.4 2 0.09 0.76
On holiday 32 1.19 7.67 10 0.45 3.8
Ongoing fungal infection 3 0.13 1.14
Out all day 9 0.33 2.16 1 0.04 0.38
Physio appointment 5 0.22 1.9
Podiatry appointment 1 0.04 0.38
Positive: do not rub toes raw unlike conventional socks 2 0.09 0.76
Positive: felt socks prevented injury from a knock 2 0.07 0.48 2 0.09 0.76
Positive: very comfortable 5 0.18 1.2 2 0.09 0.76
Positive: socks ease my leg swelling 1 0.04 0.24
Refused 11 0.41 2.64
Skin tear on leg 4 0.15 0.96
Too hot 81 3.01 19.42 25 1.12 9.51
Too hot: took the socks off 14 0.52 3.36 10 0.45 3.8
Too hot: weather too warm 95 3.53 22.78 77 3.44 29.28
Took the socks off for wound check 6 0.22 1.44 2 0.09 0.76
Uncomfortable/ill-fitting 6 0.22 1.44 3 0.13 1.14
Unhealed lesion 1 0.04 0.38
Unwell 3 0.11 0.72 2 0.09 0.76
Wearing sock on one leg only 13 0.48 3.12 22 0.98 8.37
Wearing socks as weather cool enough 4 0.15 0.96 2 0.09 0.76
Wearing socks on both legs 5 0.19 1.2 2 0.09 0.76
Wore socks in the evening only 4 0.15 0.96 1 0.04 0.38
Wore socks some of the day 22 0.82 5.28 24 1.07 9.13
Wore the socks all day 16 0.6 3.84 8 0.36 3.04
Other 3 0.13 1.14
No comment recorded 2271 84.49 Missing 1977 88.26 Missing
Total 2688 100 100 2240 100 100
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foam dressings, costed at prices to the NHS. Reflecting
the severity and duration of the injury, the dressing costs
per injury were £37.28 for injuries in the sock wearers
and £82.35 for injuries in the usual care group. For all
trial participants, including those who were not injured,
the dressing costs were £7.63 for the sock wearing group
and £15.71 for the usual care group.
The second major component of the NHS costs was the
NHS staff time needed to treat the injury. There were 107
visits to or from healthcare professionals by the 18 people
(31 skin tears) who were injured during the trial period.
Most of the visits were from community-based nursing
staff (District nurses or tissue viability specialist nurses).
There were three visits to minor injury units and two
emergency department attendances. There were 54 gen-
eral practice attendances and patients were seen by their
General Practitioner on 21 occasions. In STOPCUTS,
none of the injuries required a hospital admission or plas-
tic surgery treatment although both of these higher cost
treatments are sometimes needed for treating skin tears.
The average cost of healthcare staff attendances was
£153.44 (sd £293.19) per injury for the sock wearing
group and £234.60 (sd £403.18) per injury for the usual
care group. The cost distributions were heavily positively
skewed: the median costs per injury were much lower at
£13.00 (inter quartile range (IQR) £13.00–£174.00) for
injuries in the sock wearers and £19.50 (IQR £9.75–
£372.25) for injuries in the usual care group.
The estimate of total NHS costs included two pairs of
the protective socks costed at £30.00 per pair. On this
basis, average costs per person for all sock wearing
participants and injury treatment were £60 + £39.01 re-
spectively, totalling £99.01 (sd £157.49) and £66.38 (sd
£257.74) per person for all usual care participants.
Reflecting the fact that the majority of participants in
both groups were not injured, median costs were £60.00
for the sock wearers and £0.00 for the usual care group.
What the STOPCUTS study revealed about the actual
treatment of skin tears in the community was that:
 Skin tear injuries happened in several different ways
in a variety of settings.
 The injuries were not always immediately recognised
by the patients or their carers.
 The initial treatment of the wound was undertaken
by health professionals from a range of specialisms.
 Overall, most of the care was provided by district
nurses visiting their patients in their usual place
of residence.
 Although there was a relatively limited set of
dressing technologies used, an assortment of
different brands of dressing were used.
 There was substantial variation in the time it took
for the wounds to resolve—the duration of
treatment; 16.1% of the injuries took more than a
month to heal.
 There was no clear-cut relationship between the ini-
tial assessment of the severity of the injury as
assessed by STAR or Payne-Martin classifications
and the duration of treatment.
 The heterogeneity of cost-sensitive aspects treat-
ment regimes was reflected in the spread
Fig. 3 Decision tree for all injuries: occurrence, where and how treated by whom, with associated costs
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distribution of the estimates of the NHS costs in-
curred by a skin-tear injury—these are the estimates
of the costs that were averted when the injury was
prevented by the use of the thin skin protection
socks.
Interviews and focus groups
Twenty participants from care homes and primary care
were interviewed (13 intervention and 7 TAU group).
Participants in the intervention group had been asked
about their experiences of wearing the socks, and mem-
bers of both groups were asked how they felt about tak-
ing part in the trial. Saturation was reached in the TAU
group after 7 interviews. Three main themes arose from
participant interviews: theme 1, ‘General Involvement in
the study’—impact on quality of life. The sub-themes
were (a) ‘Impact on everyday life’—social life family and
friends; (b) ‘Motivation to take part’ and (c) ‘Coping with
being involved’. Some participants reported having
enjoyed taking part in the trial and that health profes-
sionals were impressed that they had participated. Mo-
tivation to take part was often influenced by knowing
people who suffered from skin tears and leg ulcers. In
some interviews, people mentioned having felt a sense
of altruism that had motivated them to take part in re-
search that might help sufferers even if it did not benefit
them directly. Others felt a little bothered about filling
in the diary about the sock wearing.
Theme 2 was the trial-specific experience related to com-
munication and support. The subthemes were (a) Informa-
tion given and (b) experience of being involved relating to
support and other issues. Participants remembered reading
the information, feeling fully informed about the trial and
giving their consent. They felt that the support from the re-
search nurses was very good—especially the regular contact
with them. This included those who had to drop out be-
cause they could not wear the socks. People were happy to
be randomised on the whole.
Theme 3 was the experience of wearing the socks with
subthemes of (a) general feedback, (b) specific issues
and (c) quality of life. Putting on and taking off the socks
without help from carers was an issue for some partici-
pants, e.g. one had a shoulder problem, preventing him
from putting them on. However, another care home resi-
dent bought himself a simple device to aid in putting on
socks. Once the socks were on, wearers mostly found
them comfortable. Some participants would not consider
wearing them to socialise with smart clothing. Several
people made comments about the perceived warmth of
the socks, saying that they would be happy to wear them
in winter but not in the summer (bearing in mind that
the summer of June 2014 was the hottest on record).
Certain participants felt the foot of the sock would be
loose and ‘baggy’ so that putting shoes on was difficult.
It was felt that some refinement of the design might be
beneficial. People generally felt protected by the socks,
however. Participants commented on the benefits of
wearing the socks. In some cases, they were aware that
they had knocked themselves but had no marks or
bruises on their legs when they took the socks off.
In the focus groups with care home staff and profes-
sionals, care home staff were pleased that their homes
had had the opportunity to take part in a clinical trial.
They commented on how well it was conducted and
how efficient and unobtrusive the research nurses were.
Some staff asked why residents of homes with dementia
were excluded from the trial. They felt that these were
more prone to suffering from skin tears because of their
reduced awareness of the dangers and physical obstacles.
Other comments were made about the potential benefits
of residents wearing the socks in bed because they injure
themselves at night too, perhaps just as leggings rather
than a complete sock.
Secondary outcomes: questionnaires at baseline, after
injury and at completion
Table 8 gives data on secondary outcome measures cap-
tured through questionnaires. Of the questionnaire
booklets, 90 (100%) were completed at baseline and 88%
at 16 weeks. There were 11 (12%) unobtainable ques-
tionnaire booklets at 16 weeks (and none overdue), pro-
viding full data on 79 (88%) participants (38 socks
group; 41 TAU). The best completed measure as a whole
was the EQ5D5L with 100% returned both at baseline
and at 16 weeks. The least favoured measure was the
ICECAP-O, especially for care home residents because it
forced them to focus on the negative things in their lives
and raised issues which they found unpleasant.
Contamination
Any future trial needs to consider the possibility of con-
tamination, which we assessed in this pilot. The socks
are commercially available on the internet and the study
Participant Information Sheet would have drawn atten-
tion to their existence for participants, their relatives/
carers and potentially their GPs. Any contamination that
occurred in this pilot was recorded, and there was only
one case of a patient in the TAU group obtaining a pair
of socks for himself; he had previously received 8 re-
peated skin tears in a 2-month period.
Discussion
This pilot addressed the uncertainties in planning a future
definitive randomised controlled trial. The areas of uncer-
tainty to be addressed are typical in a study of this nature:
the feasibility of recruitment (of care homes, general prac-
tices and of individual participants), the suitability of out-
come measure assessments and their timing and the
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Table 8 Secondary outcome measures
Socks group: percent completion, mean and (s.d.) or median
and (IQR). N = 44
TAU group: percent completion, mean and (s.d.) or median
and (IQR). N = 46
Measure
Completion (%)
Mean (sd)
Median (IQR)
Baseline After injury
(n = 10)
At 16 weeks Change from
baseline to
16 weeks
Baseline After injury
(n = 13)
At 16 weeks Change from
baseline to
16 weeks
EQ5D mobility 100% 100% 86.4% 100% 61.9% 89.1%
3.09 1.25) 3.10 (1.37 2.74 (1.31) − 0.35 2.83 (1.36) 2.38 (1.12) 2.56 (1.31) − 0.27
3.5 (2) 3.5 (2) 3.0 (3) − 0.5 3.0 (2) 2.0 (2) 3.0 (3) 0
EQ5D self-care 100% 100% 84.1% 100% 61.9% 87%
2.2 (1.44) 1.04 (1.62) 2.05 (1.37) − 0.15 2.46 (1.66) 1.62 (0.87) 2.10 (1.46) − 0.36
2.0 (2) 1.5 (3) 1.0 (2) − 1.0 2.0 (3) 1.0 (2) 1.0 (2) − 1.0
EQ5D usual activities 100% 100% 86.4% 97.8% 61.9% 87%.
2.64 (1.45) 3.0 (1.70) 2.54 (1.45) − 0.1 2.31 (1.31) 2.08 (1.12) 2.35 (1.44) 0.04
2.0 (3) 3.0 (4) 2.0 (3) 0 2.0 (2) 2.0 (2) 2.0 (2) 0
EQ5D pain/discomfort 100% 100% 86.4% 100% 61.9% 89.1%
2.14 (1.07) 1.80 (1.03) 1.95 (1.01) − 0.19 1.96 (0.89) 1.38 (0.77) 1.90 (0.94) − 0.06
2.0 (2) 1.5 (1) 2.0 (2) 0 2.0 (2) 1.0 (1) 2.0 (2) 0
EQ5D anxiety/
depression
100% 100% 86.4% 97.8% 61.9% 89.1%
1.3 (0.63) 1.3 (0.48) 1.50 (0.76) 0.2 1.57 (0.86) 1.31 (0.48) 1.41 (0.81) − 0.16
1.0 (0) 1.0 (1) 1.0 (1) 0 1.0 (1) 1.0 (1) 1.0 (1) 0
EQ5D utility score 100% 100% 84.1% 95.7% 61.9% 87%
0.664 (0.234) 0.649 (0.204) 0.695 (0.227) 0.031 0.673 (0.262) 0.808 (0.186) 0.731 (0.246) 0.058
EQ5D health state 84.1% 60% 65.9% 87% 52.4% 65.2%
62.62 (21.45) 63.33 (12.52) 68.66 (17.01) 6.04 67.58 (23.35) 71.45 (22.05) 69.77 (22.03) 2.19
EQ5D health state
box
90.9% 90% 81.8% 91.3% 61.9% 82.6%
62.63 (21.56) 64.44 (12.36) 71.53 (20.18) 8.9 67.50 (23.12) 73.08 (21.07) 70.13 (21.2) 2.63
ICECAP 100% 100% 100% 86.4% 61.9% 89.1%
0.737 (0.419) 0.6359 (0.2514) 0.811 (0.285) 0.074 0.767 (0.310) 0.7107 (0.2395) 0.788 (0.309) 0.021
FES 100% 100% 86.4% 100% 61.9% 89.1%
14.25 (6.16) 14.7 (5.27) 14.24 (6.31) 12.98 (5.44) 14.08 (6.78) 13.29 (6.52)
13 (8.5) 14 (10.5) 14 (10.25) 1 11(6) 11 (11) 10 (10) − 1.0
CWIS physical
symptoms and daily
living/120
N/a 100% 50% N/a 61.9% 70%
N/a 28.7 (14.85) 26.25 (4.5) − 2.45 N/a 26.62 (9.2) 32.0 (8.35) 5.38
N/a 24.5 (18) 24 (6.8) − 0.5 N/a 28 (12.5) 30 (4) 2.0
CWIS social life/70 N/a 100% 50% N/a 61.9% 70%
N/a 15.8 (13.59) 15.0 (2.0) − 0.8 N/a 15.54 (5.75) 18.0 (6.51) 2.46
N/a 7.5 (18.75) 14 (3) 6.5 N/a 15 (4.5) 15 (6) 0
CWIS wellbeing/35
(high score is worse)
N/a 90% 75% N/a 61.9% 70%
N/a 11.26 (4.73) 10.67 (4.32) − 0.59 N/a 15.84 (4.45) 17.14 (5.15) 1.3
N/a 15 (7) 9.5 (7.25) − 5.5 N/a 17 (8) 18 (5) 1.0
CWIS quality of life/20
(high score is better)
N/a 100% 62.5% N/a 61.9% 70%
N/a 13.5 (3.95) 11.8 (4.03) − 1.7 N/a 15.15 (3.21) 12.43 (6.19) − 2.72
N/a 14.5 (3.5) 14 (8) − 0.5 N/a 16 (5.5) 14 (13) − 2.0
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distribution of variables (and therefore the number of par-
ticipants needed in a full substantive trial of effectiveness).
In particular, it focussed on the acceptability of the socks.
Preliminary work and early patient and public involvement
indicated that they might not be aesthetically pleasing to
participants because of their current limited colour range
(charcoal grey or beige) and perceived thickness. Doubts
had also been raised about comfort and fitting as the size is
currently limited to four (small, medium, medium-wide
and large). We also did not know whether the socks can be
worn and tolerated during the different seasons of the year.
Working in geographical cohorts proved to be efficient
for research nurses but recruitment from care homes
was slow due to mental capacity issues among residents
and some reluctance to take part in research. Once re-
cruited, however, residents enjoyed the weekly contact
with the research nurses by phone and in person. In
order to reach our target sample, participants were re-
cruited from the community (GP practices) but they
were on average 10 years younger than those from care
homes (median 80 versus 90 years respectively). How-
ever, it was easier to recruit participants for the trial
from the community because consenting one person
only required two people to be invited. In care homes, it
required six residents to be invited. Running clinics in
GP surgeries was also less costly on travel and research
nurse time where they could see five patients in a single
morning. Seventy-nine participants (88%) completed the
trial and 27/44 (61%) in the socks group wore the socks
for the full 112 days. Of the two colours of socks avail-
able, the preferred colour was beige, although a larger
proportion of men than women preferred charcoal grey.
There were 11 withdrawals from the trial: 6 (14%) partic-
ipants in the socks group and 5 (11%) in the control
group. Of the questionnaire booklets, 100% were com-
pleted at baseline and 88% at 16 weeks. The best com-
pleted measure as a whole was the EQ5D5L.
There were 31 skin tear injuries affecting 18 of the ori-
ginal 90 participants (20%, 95% CI 12.3 to 29.8%) during
a 16-week period. The incidence of skin tears was lower
in care homes than in the community dwellers: RR 1.33
(0.73 to 2.18). In interviews, the latter confirmed that
they were more active and ventured outside more than
participants living in care homes. They were likely to be
engaged in outdoor activities such as gardening and
their injuries often related to these activities. Research
nurses reported that the socks made the wearers feel
protected and less cautious about attempting these activ-
ities. There were 21 skin tear injuries among 10 partici-
pants in the usual care group and 10 tears among 8
people in the socks group. The usual care group received
more tear injuries, more repeated episodes, larger tears
and more severe tears which would require emergency
treatment. Only 2 of the 8 people in the socks group
who received skin tear injuries were wearing their inter-
vention socks when the injuries occurred. Furthermore,
one of them was a care home resident whom carers
stated habitually rolled down their protective socks, es-
pecially during the hot weather. Twelve adverse events
had a causal relationship to wearing the socks: 8 were
mild (mostly lower leg discomfort) and 4 were moderate
(pain, swelling and a blister) but all recovered.
Daily diary reasons for not wearing the socks were var-
ied but a large proportion of comments referred to the
weather being too hot to wear them. However, these
comments were made by only 4 of 44 socks group par-
ticipants (9.1%) who were all recruited during the
record-breaking hot summer of 2014 [47]. The qualita-
tive interviews corroborated what participants had writ-
ten in their daily diaries—especially concerning the
perceived warmth of the socks. With regard to assess-
ment of skin tear severity, the STAR severity grading
system [43] fared well against the Payne-Martin system
[1], achieving ‘very good’ agreement by research nurses.
Strengths of this pilot trial were that it recruited
participants to the target sample within the time and
budget available. It included residents of care homes,
which represent an under-researched population of
older people, but such recruitment was difficult and
much easier in the primary care community. Demen-
tia was an exclusion criterion in this pilot, which lim-
ited recruitment from care homes; moreover, older
people with dementia are at even greater risk of skin
tears than those without it [8]. A future trial should
consider how best to include this group.
Randomisation using smart phones connecting to the
CTU server was very effective and efficient. Further-
more, retention and concordance with the preventative
measure were reasonable. Data on the primary outcome
was able to be captured successfully, and completeness
of questionnaire-based outcomes was also high. Diaries
were less well completed.
Within this pilot the scope for contamination was seen
to be low, but still a consideration for a future larger
trial. Cluster randomisation would not prevent control
participants seeking to purchase their own socks, but
might reduce the potential for such contamination, e.g.
because of seeing intervention patients wearing socks.
However, cluster randomisation has disadvantages, and
on balance, we recommend that a future trial uses indi-
vidual randomisation.
No known studies of prevention of skin tears to the
legs using socks woven with Kevlar exist. Current at-
tempts at prevention are not very effective. As skin tears
are caused by blunt trauma and shearing or friction
forces on the skin, methods of preventing them concen-
trate on ways of avoiding these traumas to the skin and
include [49–53]:
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 Reviewing the hazards present within the
individual’s environment and carrying out a risk
assessment in order to minimise risk
 Padding hard surfaces, including wheelchair legs and
any devices used to move the individual and
dressing them in trousers, long-sleeved tops, knee-
length socks and keeping all finger and toenails short
and filed
 Educating the people responsible for caring for the
individual in methods of gentle manual handling
whilst turning and transferring and using lift sheets
to move them in bed
 Reviewing medication to avoid polypharmacy, which
has been identified as a risk factor for falls.
 Using a hypoallergenic moisturiser to maintain
hydration for maintenance of skin integrity
Assessment of severity
There is little consistency in how skin tears are assessed
and documented. Le Blanc et al. [49] found that many of
the respondents did not use a tool or system for classify-
ing or documenting a skin tear. This could also lead to
an under-reporting of skin tears and so the prevalence
could, in fact, be much higher than previously thought.
Although the Payne-Martin classification system [1]
has been validated both internally and externally, the re-
sults were not published (K. LeBlanc, pers. comm) and
this may be why it has not been widely used in clinical
practice [54, 55]. In a large-scale international survey of
healthcare professionals’ practice and management of
skin tears, only 10% of those surveyed said that they
used the classification system in practice [54]. In fact, in
our pilot study, the STAR grading system [43] provided
similar inter-rater agreement to Payne-Martin [1] but
better intra-rater agreement. The STAR grading system
also identified more grade 2b and fewer 2a tears than
the Payne-Martin.
Risk factors
A recent systematic review described the risk factors for
skin tears, which were most commonly a history of skin
tears, impaired mobility and impaired cognition. Skin
characteristics associated with skin tears included senile
purpura, ecchymosis and oedema [16]. The group of in-
dividuals most at risk of developing a skin tear are those
with impaired mobility who rely on others for help with
activities of daily living (ADL), such as dressing, bathing
and transferring from one environment to another [55].
Also at high risk are individuals who have impaired cog-
nition and vision.
Following this, elderly individuals living independently
are also at a high risk through falls, trips and trauma in-
juries through bumping into household and garden fur-
niture [36]. The list of causes of skin tears witnessed in
this pilot study includes all of these. There was a notice-
able difference between care home residents whose in-
juries were more related to bedtime transfers and night-
time activities and the younger, more active community
participants, whose injuries were more related to activ-
ities outside (e.g. in the garden).
We selected community dwellers to approach for this
study based on searching on general practice patients
who had a history of long-term corticosteroid use. There
was an evidence base for this. Long-term use of cortico-
steroids is thought to cause changes to collagen synthe-
sis, thus increasing the susceptibility of the skin to
tearing [54–57]. Corticosteroids are thought to affect
various components of the extracellular matrix (ECM)
which consists mostly of type I collagen fibres, and thus
prevent the dynamic remodelling of skin and this con-
tributes to skin atrophy [58] and also reduce the synthe-
sis of epidermal lipids, thus increasing transepidermal
water loss.
Topical use of corticosteroids can lead to skin atrophy,
characterised by a decrease in skin thickness and elasti-
city, telangiectasia and purpura [59]. Glucocorticoids re-
duce proliferation of keratinocytes and have an adverse
effect on their size [60–62]. This is accompanied by a
decrease in the proliferation of fibroblasts and also pro-
duction of ECM proteins [63–66].
Use of anticoagulants has been linked to changes in
the skin such as haematomas, senile purpura and ec-
chymoses [1, 54, 55]. It has previously been observed
that skin tears occur often at the site of senile purpura
[51, 65, 66], and ecchymosis has been identified as an
extrinsic independent risk factor for skin tears [52]. Hae-
matomas compromise the viability of adjacent tissue,
and this can be exacerbated by the use of warfarin [67].
Skin tears often occur at sites of previous ones. This is
likely due to the healed site having a reduced tensile
strength [49, 68]. Other conditions associated with an
increased risk of developing skin tears include oedema
and diabetes mellitus. This is thought to be due to the
final common pathway of oxidative stress and over-
expression of MMPs, matrix metalloproteinase enzymes
that play an important part in wound healing [36, 69].
Individuals with diabetes mellitus are also more likely to
be at risk of delays in wound healing.
Implications for this study
The protective socks offer hope of some protection from
skin tears when very few other measures have worked
and this pilot indicates that it is worth carrying out a
full-scale definitive trial in the future to determine their
effectiveness and cost effectiveness.
Individuals at highest risk of developing skin tears are
those who are dependent on others for their activities of
daily living, such as dressing, bathing, transferring and
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re-positioning. Many of these individuals are residents in
care homes, but some will also be found in the commu-
nity. Another group at high risk of skin tears are those
ambulatory individuals who either are taking medica-
tions (e.g. long-term use of steroids or anticoagulants, or
have chronic conditions (e.g. cardiovascular or respira-
tory disease) which render their skin more susceptible to
skin tears. The participants in the next trial would,
therefore, include these groups of eligible individuals.
For a future trial, we would consider asking the partic-
ipants to wear the socks at night time as well as the day.
In this pilot trial, injuries sustained by people in the
socks group mostly occurred when the person was not
wearing them, for example at night when a person may
get out of bed and blunder into an unseen obstacle.
We would also encourage the manufacturer of the
socks to provide a larger range of colours of socks in a
wider range of sizes as limited colour choice appeared to
be a barrier to participation and the available sizes did
not fit a few people. Also, there was a perceived need for
thinner socks to cater for hot summer weather. How-
ever, changing the thickness may affect any protective
properties that the socks appear to have.
The feasibility data recorded in this trial will inform
the design of a further definitive trial to investigate
whether protective leg (and possibly arm) wear can
prevent skin tears in high risk individuals. We intend
to apply for funding from NIHR or another major
funding body.
Implications for future research
The most appropriate primary outcome measure for the
future RCT are not skin tear-free days but the incidence
of skin tears including their size and severity (as scored
by the Payne Martin and/or STAR rating system), to-
gether with the EQ5D5L and Cardiff Wound Inventory
as a secondary outcome measures.
This pilot trial demonstrated an effect of 8% points be-
tween groups (effect size 0.40) even although only 61%
of participants achieved 100% compliance with wearing
of the socks and also not at night. Given the pragmatic
nature of this trial, in a future trial we would introduce
mechanisms (encouragement phone calls) to further en-
courage adherence with trial procedures.
Refinements to the intervention arising from qualita-
tive work on acceptability could include the availability
of a greater range of sock colours, which might help to
improve recruitment.
Regarding cost and effectiveness measures, it was
not difficult to obtain the cost of dressings to treat
skin tears seen by community nurses. It was more
difficult to obtain accurate measurements of amounts
of time spent by various professionals in treating the
wounds.
Sample size for a future study
A future study would need to be multi-centre to recruit
the required numbers of participants. It would need to
be conducted in primary care because recruitment is
easier than in care homes and also this community
population are more active and exposed to more skin
tear hazards in their daily lives. Based on the difference
in incidence found in this pilot, for 90% power, this
would require 880 patient recruits.
Conclusions
We have shown that it is possible to recruit and re-
tain sufficient participants to conduct a trial of skin
tear prevention using novel protective socks in care
homes and the community.
The results from this trial are encouraging, and we
plan to conduct a future trial to investigate whether
these protective socks/leggings are effective and
cost-effective in protecting against skin tears to the
lower legs.
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